Federal contract award
75A50325C00020
RAFA ATROPINE AUTO-INJECTORS (0.5 MG, 1 MG, AND 2 MG)
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | ASPR/ORM-SNS |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $33.4M |
| Current contract value | $33.4M |
| Potential contract value / ceiling | $46.2M |
| Start date | Sep 30, 2025 |
| Current end date | Sep 29, 2027 |
| Potential end date | Sep 29, 2028 |
| Latest award activity | Jul 29, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 29, 2026 | P00001 | $12.4M | EXERCISE OPTION FOR ATROPINE AUTO-INJECTORS (0.5 MG, 1 MG, AND 2 MG) |
| Sep 30, 2025 | 0 | $20.9M | RAFA ATROPINE AUTO-INJECTORS (0.5 MG, 1 MG, AND 2 MG) |
Estimated positioning window
Sep 29, 2027 – Mar 29, 2028
55/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 55/100. Available recorded signals: 50 points.
- Contract end 2028-09-29 (705 days from calculation)
- +25 points
- 31 historical awards in this buyer and category group
- +15 points
- 2 recorded award transactions
- +5 points
- Latest award action: 2026-07-29
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.